JP2021512855A - ラクトバシラスを含む健康に有益な組成物及びその調製方法 - Google Patents

ラクトバシラスを含む健康に有益な組成物及びその調製方法 Download PDF

Info

Publication number
JP2021512855A
JP2021512855A JP2020540482A JP2020540482A JP2021512855A JP 2021512855 A JP2021512855 A JP 2021512855A JP 2020540482 A JP2020540482 A JP 2020540482A JP 2020540482 A JP2020540482 A JP 2020540482A JP 2021512855 A JP2021512855 A JP 2021512855A
Authority
JP
Japan
Prior art keywords
vaccinium
calcium
weight
berry powder
berry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020540482A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512855A5 (https=
JPWO2019150004A5 (https=
Inventor
シーア ビーズリー，
シーア ビーズリー，
エイラ ヤルヴェンパー，
エイラ ヤルヴェンパー，
ヤルッコ マキネン，
ヤルッコ マキネン，
トゥオモ トゥパセラ，
トゥオモ トゥパセラ，
ヤーコ ヒイデンホヴィ，
ヤーコ ヒイデンホヴィ，
カレヴィ ヘイノネン，
カレヴィ ヘイノネン，
Original Assignee
ヴェットケアー オイ
ヴェットケアー オイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴェットケアー オイ, ヴェットケアー オイ filed Critical ヴェットケアー オイ
Publication of JP2021512855A publication Critical patent/JP2021512855A/ja
Publication of JP2021512855A5 publication Critical patent/JP2021512855A5/ja
Publication of JPWO2019150004A5 publication Critical patent/JPWO2019150004A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
JP2020540482A 2018-02-05 2019-02-05 ラクトバシラスを含む健康に有益な組成物及びその調製方法 Pending JP2021512855A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20185099A FI128916B (en) 2018-02-05 2018-02-05 Health-promoting composition and method for its preparation
FI20185099 2018-02-05
PCT/FI2019/050080 WO2019150004A1 (en) 2018-02-05 2019-02-05 Health beneficial composition comprising lactobacillus and method for the preparation thereof

Publications (3)

Publication Number Publication Date
JP2021512855A true JP2021512855A (ja) 2021-05-20
JP2021512855A5 JP2021512855A5 (https=) 2022-01-20
JPWO2019150004A5 JPWO2019150004A5 (https=) 2022-01-20

Family

ID=65529725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540482A Pending JP2021512855A (ja) 2018-02-05 2019-02-05 ラクトバシラスを含む健康に有益な組成物及びその調製方法

Country Status (6)

Country Link
US (1) US20200360452A1 (https=)
EP (1) EP3749341A1 (https=)
JP (1) JP2021512855A (https=)
CA (1) CA3090549A1 (https=)
FI (1) FI128916B (https=)
WO (1) WO2019150004A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102568460B1 (ko) * 2023-03-08 2023-08-25 주식회사 한국그린바이오 대마줄기를 활용한 동물사료 및 그의 제조방법
JP2024518221A (ja) * 2021-09-28 2024-05-01 上海信元寵物食品有限公司 ワイセラ・コンフューザ、培養方法及びその応用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900016850A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Composizioni a base di ceppi batterici e estratti di bacche e loro uso come antinfiammatori
IT201900019325A1 (it) * 2019-10-18 2021-04-18 Ghs Gemelli Health System S R L Miscela comprendente estratti di frutti, e polifenoli estratti da foglie o frutti di Olea Europaea L. e inulina e uso di tale composizione nel trattamento di malattie infiammatorie acute e croniche, localizzate o sistemiche, o conseguenti ad un’ischemia o a un’alterazione della funzionalità dell’endotelio vasale
CL2019003739A1 (es) * 2019-12-18 2020-06-19 Univ Concepcion Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos.
CN121220706B (zh) * 2025-12-02 2026-04-10 杭州传趋生物科技有限公司 一种基于Lactobacillus复合菌群与药用真菌提取物的女性健康调理组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007326858A (ja) * 2006-06-08 2007-12-20 Chih-Hsiung Lin 泌尿系感染の予防又は治療に使用される組成物
WO2011018547A1 (en) * 2009-08-12 2011-02-17 Vetcare Oy Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders
JP2016518411A (ja) * 2013-05-06 2016-06-23 バックスアルタ インコーポレイテッド プールされた免疫グロブリンｇを用いたアルツハイマー病の亜集団の治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
EP1290136B1 (en) 2000-05-25 2006-05-10 Société des Produits Nestlé S.A. Probiotics for pet food applications
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ATE541469T1 (de) 2005-12-29 2012-02-15 Hills Pet Nutrition Inc Verfahren zum modifizieren der darmflora bei tieren
WO2015017625A1 (en) * 2013-07-31 2015-02-05 Wikifoods, Inc. Encapsulated functional food compositions
TWI788111B (zh) * 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007326858A (ja) * 2006-06-08 2007-12-20 Chih-Hsiung Lin 泌尿系感染の予防又は治療に使用される組成物
WO2011018547A1 (en) * 2009-08-12 2011-02-17 Vetcare Oy Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders
JP2016518411A (ja) * 2013-05-06 2016-06-23 バックスアルタ インコーポレイテッド プールされた免疫グロブリンｇを用いたアルツハイマー病の亜集団の治療

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024518221A (ja) * 2021-09-28 2024-05-01 上海信元寵物食品有限公司 ワイセラ・コンフューザ、培養方法及びその応用
JP7570148B2 (ja) 2021-09-28 2024-10-21 上海信元寵物食品有限公司 ワイセラ・コンフューザ、培養方法及びその応用
KR102568460B1 (ko) * 2023-03-08 2023-08-25 주식회사 한국그린바이오 대마줄기를 활용한 동물사료 및 그의 제조방법

Also Published As

Publication number Publication date
EP3749341A1 (en) 2020-12-16
CA3090549A1 (en) 2019-08-08
WO2019150004A1 (en) 2019-08-08
US20200360452A1 (en) 2020-11-19
FI128916B (en) 2021-03-15
FI20185099A1 (en) 2019-08-06

Similar Documents

Publication Publication Date Title
FI122247B (fi) Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
JP2021512855A (ja) ラクトバシラスを含む健康に有益な組成物及びその調製方法
US20210054467A1 (en) Novel lactobacillus plantarum and composition comprising the same
Guerra et al. Production of four potentially probiotic lactic acid bacteria and their evaluation as feed additives for weaned piglets
JP5438003B2 (ja) ラクトバチルスラムノサス及び体重管理
JP2022511893A (ja) ワイセラ・シバリアｗｉｋｉｍ２８を有効成分として含む癌の予防又は治療用薬学組成物
JP7052092B2 (ja) 抗ウイルス及び免疫調節効能を有するラクトバチルス・プランタルムｃｊｌｐ１７及びそれを含む組成物
JP2003501080A (ja) ヒトおよび動物に使用される細菌株、加工された植物抽出物およびプロバイオティック組成物
BR112019026814A2 (pt) cepa cjlp475 de lactobacillus plantarum, composição, e, métodos para melhorar a imunidade de um indivíduo, para prevenir ou tratar uma doença infectada por vírus de um indivíduo, para preparar uma composição probiótica
CN102524539B (zh) 一种动物保健剂组合物及其制备工艺
US20250113852A1 (en) Human food product
JP6918144B2 (ja) ラクトバチルス・プランタルムｃｊｌｐ４７５菌株とラクトバチルス・プランタルムｃｊｌｐ２４３菌株とを含む組成物及びその用途
KR20160039097A (ko) 페디오코커스 펜토사세우스 ｗｉｋｉｍ20 및 이를 포함하는 조성물
JP2009000045A (ja) 飼料配合剤
KR20160007964A (ko) 락토바실러스플란타룸 ｗｉｋｉｍ１８ 및 이를 포함하는 조성물
JP2019182763A (ja) 組成物、およびそれを含む食品および飼料
JP2021182889A (ja) 肺機能改善用組成物、および肺疾患の予防、治療または症状軽減用組成物
KR102674853B1 (ko) 신규한 락토바실러스 람노서스 fb019 균주 및 이를 포함하는 식품 조성물
US20240091281A1 (en) Pharmaceutical composition for preventing or treating intestinal damage comprising leuconostoc citreum strain as active ingredient
JP2008050306A (ja) 動物の免疫調節剤
JP2026011900A (ja) 腸内環境を改善するための、長命草およびビフィドバクテリウム・アニマリスの組み合わせ
KURIAKOSE EFFECT OF DIETARY INCORPORATION OF ENCAPSULATED PROBIOTICS ON GROWTH PERFORMANCE OF LARGE WHITE YORKSHIRE CROSSBRED PIGLETS
WO2022169336A2 (ko) 류코노스톡 시트래움 균주를 유효성분으로 포함하는 섬유화증의 예방 또는 치료용 약학 조성물
Balance PROBIOTIC 225

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200721

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221028

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221031

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230523